Browse by Aston Author

2009

Russell, Steve T.; Siren, P.M.A.; Siren, M.J. and Tisdale, Michael J. (2009). Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate. Cancer Chemotherapy and Pharmacology, 64 (3), pp. 517-527.

Eley, Helen L.; McDonald, Pria S.; Russell, Steve T. and Tisdale, Michael J. (2009). Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition. Cancer Chemotherapy and Pharmacology, 63 (4), pp. 651-659.

Russell, Steve T.; Rajani, Seema; Dhadda, Raj S. and Tisdale, Michael J. (2009). Mechanism of induction of muscle protein loss by hyperglycaemia. Experimental Cell Research, 315 (1), pp. 16-25.

2008

Eley, Helen L.; Russell, Steve T. and Tisdale, Michael J. (2008). Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. American Journal of Physiology, 295 (6), E1417-E1426.

Eley, H.L.; Russell, Steve T. and Tisdale, Michael J. (2008). Role of the dsRNA-dependent protein kinase (PKR) in the attenuation of protein loss from muscle by insulin and insulin-like growth factor-I (IGF-I). Molecular and Cellular Biochemistry, 313 (1-2), pp. 63-69.

Russell, Steve T.; Eley, Helen L.; Wyke, Stacey M. and Tisdale, Michael J. (2008). Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochemical Journal, 409 (Part 3), pp. 751-759.

2007

Russell, Steve T.; Eley, Helen and Tisdale, Michael J. (2007). Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I). Cellular Signalling, 19 (7), pp. 1583-1595.